American Conference Institute's 6th Annual Summit on
The Definitive Forum on the Legal, Regulatory, Patent, and Commercial Realities of Follow-On Biologics
Monday, June 01 to Wednesday, June 03, 2015
Affinia Manhattan, New York, NY
Attend the premier event where the industry leaders from both innovator and biosimilar companies convene to formulate solutions to the complex regulatory and patent challenges ahead as the first biosimilars become a reality in the U.S
At long last, companies are officially moving forward with the first U.S. biosimilar applications and the FDA has given its stamp of approval to at least one. As a sign of the hard-fought IP battles to come, multiple lawsuits have been filed under the BPCIA, even in the absence of final FDA guidance.
Since the passage of the historic Biologics Price Competition & Innovation Act (BPCIA) in 2010, the key figures shaping the evolving biosimilar landscape---in-house counsel from leading biopharmaceutical companies, top IP and regulatory lawyers, key policy and industry insiders, the FDA, and the FTC- have convened to formulate solutions to the challenges facing the industry at the ACI Biosimilars conference. Topics to be discussed this year include:
Hear What Prior Attendees are Saying about this Annual Leading Event:
Full conference details are on the way shortly. If you are interested in speaking at this event, contact Nicole Cutrufello-Turner at email@example.com. For information on sponsoring or exhibiting at this event, contact Esther Fleischhacker at firstname.lastname@example.org.
Based on past success, spaces will fill up quickly. Register now by calling 888-224-2480, faxing your registration form to 877-927-1563 or registering online at www.AmericanConference.com/Biosimilars
- Actions -
- Share -
Mon, Jun 01, 2015
Wed, Jun 03, 2015
New York, NY